Investor Alert

New York Markets Open in:

HilleVax Inc.



After Hours

 --Quotes are delayed by 20 min

Sep 25, 2023, 4:01 p.m.





0.00 0.00%


Volume 105

Quotes are delayed by 20 min


Previous close

$ 13.04

$ 13.08


+0.04 +0.31%

Day low

Day high




52 week low

52 week high




Julie Louise Gerberding

Julie Louise Gerberding is President, Chief Executive Officer & Director at Foundation for the National Institutes of Health, Inc., Member of National Academy of Public Administration and Member of National Academy of Medicine (United States) and on the board of 8 other companies.

In the past Dr. Gerberding was Chief Patient Officer & EVP-Communication at Merck & Co., Inc. Co-Chairman at MSD Vaccines Ltd. and President at Merck Vaccine Division (both are subsidiaries of Merck & Co., Inc.) and Director at Centers for Disease Control & Prevention.

Dr. Gerberding received a doctorate and an undergraduate degree from Case Western Reserve University and a graduate degree from the University of California, Berkeley.


Date Shares Transaction Value

Officers and Executives

Dr. Robert M. Hershberg
Chairman, President & Chief Executive Officer
Dr. Aditya Kohli
Chief Operating Officer & Director
Mr. Shane Maltbie
Chief Financial Officer
Dr. Astrid Borkowski
Chief Medical Officer
Dr. Anju Chatterji
Chief Technology Officer
Mr. Paul S. Bavier
Secretary & Chief Administrative Officer
Mr. David A. Socks
Chief Business Officer
Mr. Ozzie Berger
Senior Vice President-Regulatory Affairs
Dr. Nanette Cocero
Independent Director
Dr. Gary Dubin
Independent Director
Dr. Shelley Chu
Independent Director
Dr. Julie Louise Gerberding
Independent Director
Mr. Patrick J. Heron
Independent Director
Ms. Jeryl Lynn Hilleman
Independent Director
Dr. Jaime Sepulveda
Independent Director
Link to MarketWatch's Slice.